Add BrightSurf on Google Email

Oncotarget | Glypican-3 (GPC3) is associated with MCPyV-negative status and impaired outcome in Merkel cell carcinoma

Researchers found that Merkel cell carcinoma (MCC) Glypican-3 (GPC3) is expressed in nearly 70% of MCC tumors and up to 90% of MCPyV-negative cases. GPC3 expression is associated with worse prognosis, including increased risk of death from MCC. This makes GPC3 a promising target for chimeric antigen receptor T cell therapy.

SourceImpact Journals LLC·JournalOncotarget·TypeExperimental study·DateAug 11, 2022

A powerful strategy for developing microbial cell factories by employing synthetic small RNAs

A Korean research team at KAIST has developed a powerful strategy for developing high-performance microbial cell factories by employing synthetic small RNAs. This approach allows for rapid identification of multiple genes to be attenuated in multiple strains simultaneously, making it easier to find the best platform strain.